4-phenyl-3-furoxancarbonitrile has been researched along with 4-ethoxy-3-phenylsulfonylfuroxan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguirre, G; Bertinaria, M; Boiani, L; Cazzulo, JJ; Cerecetto, H; Chidichimo, A; González, M; Guglielmo, S | 1 |
| Berardi, F; Chegaev, K; Colabufo, NA; Crosetti, M; Fruttero, R; Gasco, A; Guglielmo, S; Niso, M; Panaro, MA; Perrone, R | 1 |
2 other study(ies) available for 4-phenyl-3-furoxancarbonitrile and 4-ethoxy-3-phenylsulfonylfuroxan
| Article | Year |
|---|---|
Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.
Topics: Animals; Dose-Response Relationship, Drug; Leishmania; Molecular Structure; Nitrites; Oxadiazoles; Parasitic Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship; Sulfhydryl Compounds; Trypanocidal Agents; Trypanosoma cruzi | 2008 |
Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Proliferation; Dogs; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Oxadiazoles; Structure-Activity Relationship; Sulfones | 2010 |